Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CPT2 | P23786 | 1/20 | 0.30 |
| ▸ | CPT1A | P50416 | 1/20 | 0.30 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.30 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.30 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.30 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zinc Ion SCHEMBL2582011 | 0.85 | FAAH (0.35) | FAAHKMT2AMEN1MAPK1 | |
| SCHEMBL2580938 | 0.84 | FAAH (0.56) | FAAHKMT2AMEN1MAPK1PLA2G10 | |
| SCHEMBL2580940 | 0.84 | FAAH (0.56) | FAAHKMT2AMEN1MAPK1PLA2G10 | |
| Zinc Ion SCHEMBL2583762 | 0.82 | PRSS1 (0.32) | KMT2AMEN1 | |
| Zinc Ion SCHEMBL2585203 | 0.82 | NMT1 (0.34) | KMT2AMEN1NOD1 | |
| SCHEMBL2582839 | 0.82 | KMT2A (0.53) | FAAHKMT2AMEN1MAPK1PLA2G10 | |
| Zinc Ion SCHEMBL2574083 | 0.81 | NOD1 (0.44) | FAAHKMT2AMEN1MAPK1CPT2 | |
| Zinc Ion SCHEMBL2577660 | 0.81 | KMT2A (0.33) | KMT2AMEN1SLC6A5NOD1 | |
| Zinc Ion SCHEMBL2580359 | 0.81 | EPHX2 (0.42) | KMT2ACPT2CPT1ACPT1BNOD1 | |
| SCHEMBL2576072 | 0.80 | KMT2A (0.51) | FAAHKMT2AMEN1MAPK1PLA2G10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8048911-B2 | Melanin eliminator preparation | OGA Research, Inc. (JP) | 2011-11-01 | — | — | US | disclosed |
| US-20090093541-A1 | MELANIN ELIMINATOR PREPARATION | OGA RESEARCH, INC (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20060122100-A1 | Melanin extinguisher | OGA RESEARCH, INCORPORATED (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1547590-A1 | MELANIN EXTINGUISHER | Oga Research, Incorporated (JP) | 2005-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122100-A1 | Melanin extinguisher | TYR, MC1R, MITF | FAAH 4202/4885KMT2A 1597/4885MEN1 492/4885 |
| US-20090093541-A1 | MELANIN ELIMINATOR PREPARATION | TYR, MC1R, MCHR1 | FAAH 3678/4885KMT2A 1749/4885MEN1 435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.